It is of some concern that the underlying prevalence of occult prostate cancer in men with low testosterone levels appears to be substantial, according to our own study in which 77 men with hypogonadism who had normal PSA levels and normal results on digital rectal examinations underwent sextant prostate biopsy before receiving testosterone-replacement therapy.